Literature DB >> 10440414

The CAPRIE trial: culmination of the preregistration program for clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events. Clopidogrel versus aspirin in patients at risk of ischaemic events.

M Gent1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10440414

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  2 in total

Review 1.  Antiplatelet therapies for secondary stroke prevention: an update on clinical and cost-effectiveness.

Authors:  Julia M Rothlisberger; Bruce Ovbiagele
Journal:  J Comp Eff Res       Date:  2015-08       Impact factor: 1.744

2.  Efficacy and safety of low-dose clopidogrel after 12-month dual antiplatelet therapy for patients having drug-eluting stent implantation.

Authors:  Xiao-Dong Zhuang; Ming Long; Cui-Ling Li; Cheng-Heng Hu; Zhi-Ming Du; Xin-Xue Liao
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.